We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Oxoid Announces Infection Control Awards

By HospiMedica staff writers
Posted on 05 May 2005
The first prize in the 2004/2005 Oxoid Infection Control Team of the Year Awards was won by Kingston Hospital NHS (National Hospital Service) Trust (Kingston-on-Thames, UK). More...


In awarding the first prize of U.S.$9,500, the judges commented that this small infection control team showed numerous examples of good practice that could be emulated by others and had a proactive and practical approach. Its successes included reduced infection rates in orthopedic surgery, implementation of Creutzfeldt-Jakob disease guidance, instigation of an intravenous implementation group to look at improving practices, and hand hygiene audits that have led to raised compliance. The team members' commitment to education and the sharing of knowledge has also produced results, as they held infection-control conferences that have been attended by other hospitals, general practitioners, and healthcare workers.

The second prize of $1,900 went to Sanatorio Adventista del Plata (Entre Rios, Argentina). With very limited resources and support, this infection control team has demonstrated significant improvements in infection prevention and control. The team has taught patients, clinical staff, and visitors about infection prevention and control procedures, written infection-control manuals, and has substantially reduced the rates of nosocomial infection in intensive care units (ICUs) and surgical sites.

The third prize of $950 went to a team at Doncaster and Bassetlaw Hospitals (Doncaster, UK), whose main challenge is to provide an integrated service across widely spaced locations up to 20 miles apart. The team demonstrated a coordinated approach to microbiologic procedures within the laboratories at Doncaster Royal Infirmary and collaborated with the antibiotic pharmacist and surgeons to produce a unified prescribing policy in orthopedic surgery, with resulting savings and reduced antibiotic selection pressure.

Oxoid (Basingstoke, UK) makes these awards every year. To register for information on how to enter, e-mail Val Kane (val.kane@oxoid.com).




Related Links:
Oxoid

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.